THERAPEUTICSMD, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
EPS (Diluted)
$-0
Book Value Per Share
$2
Free Cash Flow Per Share
$0
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$0
Return on Equity
-2.1%
Return on Assets
-1.5%
Return on Invested Capital
-12.8%
Debt to Equity
—
Current Ratio
3.02
Quick Ratio
3.02
Asset Turnover
0.08
Days Sales Outstanding
—
Days Payables Outstanding
—
Days Inventory On Hand
—
Cash Conversion Cycle
—
R&D / Revenue
—
SBC / Revenue
2.5%
Capex / Revenue
—
Working Capital
$10M
Net Current Asset Value
$4M
Invested Capital
$27M
OCF / Net Income
-4.31
FCF / Net Income
-4.31
Accruals Ratio (Sloan)
-8.0%
Net Debt
$-5M
Net Debt / EBITDA
0.90
Interest Coverage
-548.75
Cash Coverage
306.75
Capex Coverage
—
Tangible Common Equity
$23M
TCE / Total Assets
61.4%
NOPAT
$-3M
Cash ROIC
9.0%
WC / Revenue
319.7%
Capex / D&A
—
Reinvestment Rate
8.7%
Asset Growth vs Revenue Growth
-74.6%
Revenue 5Y CAGR
-45.8%
Book Value 5Y CAGR
24.4%
Stock Price (FY-end)
$2
Market Cap
$19M
P/E Ratio
—
P/S Ratio
6.24
P/B Ratio
0.70
P/TB Ratio
0.82
P/OCF Ratio
7.68
P/FCF Ratio
7.68
Enterprise Value
$19M
EV / EBITDA
—
EV / Sales
6.24
EV / FCF
7.68
FCF Yield
13.0%
Shareholder Yield
-0.4%
R&D Yield
—
Capex Yield
—
Graham Number
—
Shares Variation (YoY)
0.3%
Beta (5Y)
0.90
Cost of Equity
9.0%
Cost of Debt (after tax)
—
WACC
—
ROIC - WACC Spread
—
52W High
$2
52W Low
$1
Trailing Return 1Y
49.5%
Trailing Return 5Y
-97.3%
F-Score (Piotroski)
5.00
M-Score (Beneish)
—
Z-Score (Altman)
-34.36
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.